West Pharma (WST) Reports Q3 EPS of $0.44
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $329.71 --0%
EPS Growth %: +13.0%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +13.0%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q3 EPS of $0.44, versus $0.44 reported last year. Revenue for the quarter came in at $344.5 million, versus $355.9 million reported last year.
West Pharma sees FY2015 EPS of $1.79-$1.84.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
